Showing results (251-260 of 961) with videos related to
Sort By:
Pageof 97
Ejhaem|January 27, 2025
Single-center off-label benralizumab use for refractory hypereosinophilic syndrome demonstrates satisfactory safety and efficacyYvonne Veltman, Anna M Aalbers, Maud A W Hermans, et al.Ejhaem|January 29, 2025
Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferationXiaoxian Zhao, Deepa Jagadeesh, Juraj Bodo, et al.Ejhaem|January 28, 2025
Chronic Severe Neutropenia Associated With Intravenous Immunoglobulin for Multifocal Motor NeuropathyShannon Ugarte, Talia Gebhard, David R Cornblath, et al.Ejhaem|January 27, 2025
CD58 expression does not impact response to inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemiaRafael Madero-Marroquin, Ryan W Hunter, Caner Saygin, et al.Ejhaem|January 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and DexamethasoneTobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen, et al.Ejhaem|January 27, 2025
Red blood cell transfusion and the use of intravenous iron in iron-deficient patients presenting to the emergency departmentKevin Thomas, Arvand Barghi, Robert Balshaw, et al.Ejhaem|December 18, 2024
The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practiceRui Bergantim, Catarina Geraldes, Cristina João, et al.Ejhaem|December 18, 2024
Immediate improvement in patient care: Auditing adherence to the British Society for Haematology guidelines on screening and management of the long-term consequences of multiple myeloma and treatmentKerrie Sweeney, Aaron Niblock, Diana Greenfield, et al.Ejhaem|December 18, 2024
Dosing strategy of intrapleural bortezomib for myelomatous pleural effusion: A case report and review of literatureYu-Ming Li, Mei-Hua Tsou, Tran-Der TanPageof 97